Résultats pour "1" dans Maladie et pathologies physiques

An introduction to contents of Module 1 of our Comprehensive Course, designed for medical professionals looking to work in English speaking countries.

Le Diabète de Type 1...on en parle?Diabétiques, proches, médecins, scientifiques...qu'ils le vivent de près ou de loin, ils ont tous quelque chose à partager autour du Diabète de Type 1.Expérience, conseils, perspectives...Ils parlent.On les écoute?🚀 E-mail pour me contacter · hi@happy-diabetes.com🔥 Pour découvrir Happy Diabetes · happy-diabetes.com👉 Les Formations Happy Diabetes · https://happy-diabetes.com/formations👉 Le Coaching sur-mesure Happy Diabetes · https://happy-diabetes.com/coaching📍 Instagram · @happy_diabetes_type_1 · https://...

Host Julia Cartwright dissects the GLP-1 weight loss revolution transforming American health—examining explosive prescription growth, dramatic clinical results, and the cultural firestorm around drugs like Ozempic and Wegovy. She explores what happens when a weekly injection collides with billion-dollar industries, body politics, and the eternal promise of a quick fix. For more content like this, visit QuietPlease.ai

Host Julia Cartwright investigates why GLP-1 drugs have become a game-changer for women over 40 struggling with perimenopausal weight gain. Each episode examines the science behind hormonal metabolism shifts, clinical trial results across reproductive stages, and critical safety concerns including bone density loss and muscle depletion. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like Ozempic and Wegovy work at the cellular level to transform metabolism. Dr. Ben Synth breaks down the molecular mechanisms that slow digestion, rewire hunger signals in your brain, and regulate blood sugar through your pancreas—revealing the sophisticated biological cascade behind these groundbreaking treatments. For more content like this, visit QuietPlease.ai

Blending expert insight, practical advice, and anatomically accurate fart jokes, Sackier, Hunt, and Guest explain everything about diverticulosis and diverticulitis—and how to stop these colonic miscreants from affecting you, including: How digestion works – and what to do when it doesn’t. How to avoid ending up with a designer colostomy bag. What Joseph Pujole (pronounced poo-hole) a 19th-century French farting performer can teach you.

Host Julia Cartwright investigates how GLP-1 medications—originally created for diabetes and weight loss—may revolutionize treatment for polycystic ovary syndrome by targeting insulin resistance, restoring hormonal balance, and offering new hope for fertility. Each episode examines the science, patient experiences, and critical gaps in research shaping this emerging therapeutic frontier. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores how GLP-1 drugs are emerging as a potential game-changer for women with polycystic ovary syndrome, a condition where insulin resistance, weight gain, and hormonal imbalance fuel each other in a relentless cycle. Each episode examines how these medications may help break that cycle and restore metabolic and reproductive health. For more content like this, visit QuietPlease.ai

Benvenuti su InForma, il podcast di MedNow il Medical Center che mette la salute al centro!In questo spazio dedicato alla prevenzione, al benessere e all’informazione medico-scientifica affronteremo temi di attualità sanitaria e intervisteremo professionisti della salute.Uno podcast pensato per chi cerca informazioni corrette, basate su evidenze e vuole prendersi cura della propria salute ogni giorno!Tutti gli specialisti che intervisteremo collaborano con il nostro centro 👉 prenota le tue visite su mednow.it

Clare Delish pits GLP-1 drugs against ketogenic diets in a no-nonsense breakdown of how each method works, what the science actually shows, and the side effects hiding in the fine print. Expect biology, skepticism, and real talk about trade-offs before you pick a side in the weight loss wars. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores why GLP-1 medications have surged among women navigating perimenopause and menopause. Each episode unpacks clinical trial data, safety concerns, and surprising benefits beyond weight loss—from hormone interactions to metabolic changes—helping women over 40 make evidence-based decisions about these drugs. For more content like this, visit QuietPlease.ai

Explore the groundbreaking science behind GLP-1 drugs and addiction with Dr. Ben Synth. From shared brain reward pathways to landmark veteran studies, discover how medications for diabetes and weight loss may revolutionize treatment for alcohol, opioid, nicotine, and gambling addiction. Evidence-based insights into psychiatry's most promising frontier. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores how GLP-1 weight loss drugs are revolutionizing obstructive sleep apnea treatment, following tirzepatide's groundbreaking FDA approval. From clinical trial results to biological mechanisms and access barriers, this series examines whether these drugs offer real hope beyond the CPAP machine for millions of Americans. For more content like this, visit QuietPlease.ai

GLP-1 drugs like Ozempic trigger dramatic weight loss, but up to 40% may be muscle, not fat. Dr. Ben Synth unpacks the hidden metabolic cost, science-backed preservation strategies, and breakthrough therapies that could revolutionize how we lose weight without losing strength. For more content like this, visit QuietPlease.ai

Oral GLP-1 medications promise weight-loss results without needles, but can a daily pill with minimal absorption truly rival the proven power of weekly injections? Host Julia Cartwright unpacks the science, compares real-world trade-offs, and explores how new pricing models could finally make these drugs accessible to millions. For more content like this, visit QuietPlease.ai

Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like semaglutide are revolutionizing kidney disease treatment, cutting risk by 24% in landmark trials. Join host Julia Cartwright as she uncovers the science, breakthrough research, and future of kidney protection for millions with chronic kidney disease. For more content like this, visit QuietPlease.ai

Discover how GLP-1 drugs like Ozempic and Wegovy might do far more than trim waistlines—they could slow aging itself by quieting chronic inflammation. Dr. Ben Synth unpacks the molecular science, clinical trials, and provocative evidence linking these medications to longevity, disease prevention, and biological age reversal. For more content like this, visit QuietPlease.ai

Discover the science behind GLP-1 drugs like Ozempic, Wegovy, and Mounjaro with Dr. Ben Synth. Understand how these medications work at the molecular level, why they're so effective for weight loss and diabetes, and what the expanding research means for conditions from heart disease to Alzheimer's. For more content like this, visit QuietPlease.ai

Tired of managing blood sugar with pills, strict diets, and constant stress? You’re not alone. Millions are seeking a better solution — and Dr. Sebi’s alkaline approach could be the breakthrough you’ve been waiting for. This isn’t just another plant-based guide. It’s a practical, no-fluff system rooted in Dr. Sebi’s healing philosophy to help rebalance your body, naturally lower blood sugar, and boost energy — without meds or side effects.